KIT and gastrointestinal stromal tumor: In this study, we engineer the T670I mutation into the mouse c-kit locus, an allele originally identified in GIST patients with refractory responses to imatinib [6], and bred the strain onto the NOD background to generate imatinib-resistant c-Kit mice that develop T1D.